• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过研磨海绵状聚乳酸-羟基乙酸共聚物(PLGA)微球制备PLGA纳米颗粒

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres.

作者信息

Lee Jimin, Sah Hongkee

机构信息

College of Pharmacy, Ewha Womans University, 52 Ewhayeodaegil, Seodaemun-gu, Seoul 03760, Korea.

出版信息

Pharmaceutics. 2022 Jul 24;14(8):1540. doi: 10.3390/pharmaceutics14081540.

DOI:10.3390/pharmaceutics14081540
PMID:35893796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330877/
Abstract

Currently, emulsification-templated nanoencapsulation techniques (e.g., nanoprecipitation) have been most frequently used to prepare poly-,-lactide--glycolide (PLGA) nanoparticles. This study aimed to explore a new top-down process to produce PLGA nanoparticles. The fundamental strategy was to prepare spongelike PLGA microspheres with a highly porous texture and then crush them into submicron-sized particles via wet milling. Therefore, an ethyl formate-based ammonolysis method was developed to encapsulate progesterone into porous PLGA microspheres. Compared to a conventional solvent evaporation process, the ammonolysis technique helped reduce the tendency of drug crystallization and improved drug encapsulation efficiency accordingly (solvent evaporation, 27.6 ± 4.6%; ammonolysis, 65.1 ± 1.7%). Wet milling was performed on the highly porous microspheres with a D of 64.8 μm under various milling conditions. The size of the grinding medium was the most crucial factor for our wet milling. Milling using smaller zirconium oxide beads (0.3~1 mm) was simply ineffective. However, when larger beads with diameters of 3 and 5 mm were used, our porous microspheres were ground into submicron-sized particles. The quality of the resultant PLGA nanoparticles was demonstrated by size distribution measurement and field emission scanning electron microscopy. The present top-down process that contrasts with conventional bottom-up approaches might find application in manufacturing drug-loaded PLGA nanoparticles.

摘要

目前,乳化模板纳米包封技术(如纳米沉淀法)已最常用于制备聚丙交酯-乙交酯(PLGA)纳米颗粒。本研究旨在探索一种新的自上而下的方法来生产PLGA纳米颗粒。基本策略是制备具有高度多孔结构的海绵状PLGA微球,然后通过湿磨将其粉碎成亚微米级颗粒。因此,开发了一种基于甲酸乙酯的氨解方法,将黄体酮包封到多孔PLGA微球中。与传统的溶剂蒸发法相比,氨解技术有助于降低药物结晶的趋势,并相应提高药物包封效率(溶剂蒸发法,27.6±4.6%;氨解,65.1±1.7%)。在各种研磨条件下,对平均直径为64.8μm的高度多孔微球进行湿磨。研磨介质的尺寸是我们湿磨的最关键因素。使用较小的氧化锆珠(0.3~1mm)进行研磨根本无效。然而,当使用直径为3mm和5mm的较大珠子时,我们的多孔微球被研磨成亚微米级颗粒。通过尺寸分布测量和场发射扫描电子显微镜对所得PLGA纳米颗粒的质量进行了表征。与传统的自下而上方法形成对比的当前自上而下方法可能会在载药PLGA纳米颗粒的制造中找到应用。

相似文献

1
Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres.通过研磨海绵状聚乳酸-羟基乙酸共聚物(PLGA)微球制备PLGA纳米颗粒
Pharmaceutics. 2022 Jul 24;14(8):1540. doi: 10.3390/pharmaceutics14081540.
2
Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process.应用于微球制造工艺的非卤代有机溶剂的鉴定
Pharmaceutics. 2020 May 6;12(5):425. doi: 10.3390/pharmaceutics12050425.
3
Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles.直接在有机 PLGA 溶液中药物粉碎有助于将纳米药物包封到 PLGA 微球中。
Eur J Pharm Biopharm. 2023 Oct;191:1-11. doi: 10.1016/j.ejpb.2023.08.006. Epub 2023 Aug 12.
4
Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.载胰岛素双壁聚(丙交酯-共-乙交酯)微球的制备、表征及体外释放研究
Drug Deliv Transl Res. 2016 Jun;6(3):308-18. doi: 10.1007/s13346-016-0278-y.
5
Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.蛋白质药物的微囊化给药:策略、制备及应用。
J Control Release. 2014 Nov 10;193:324-40. doi: 10.1016/j.jconrel.2014.09.003. Epub 2014 Sep 10.
6
Dry fabrication of poly(dl-lactide-co-glycolide) microspheres incorporating a medium molecular drug by a ball mill method.球磨法干法制备载中等分子药物的聚(DL-丙交酯-乙交酯)微球。
Drug Discov Ther. 2021 Mar 10;15(1):20-27. doi: 10.5582/ddt.2021.01004. Epub 2021 Feb 24.
7
Investigation on structural integrity of PLGA during ammonolysis-based microencapsulation process.基于氨解的微囊化过程中 PLGA 的结构完整性研究。
Int J Pharm. 2011 Oct 31;419(1-2):60-70. doi: 10.1016/j.ijpharm.2011.07.022. Epub 2011 Aug 4.
8
Development of 5-iodo-2'-deoxyuridine milling process to reduce initial burst release from PLGA microparticles.
Int J Pharm. 1999 Feb 15;178(2):257-68. doi: 10.1016/s0378-5173(98)00380-9.
9
Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres.甲酸乙酯——用于制备聚乳酸-羟基乙酸共聚物(PLGA)微球的替代分散溶剂。
Int J Pharm. 2000 Feb 15;195(1-2):103-13. doi: 10.1016/s0378-5173(99)00379-8.
10
Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.载牛血清白蛋白的双层葡萄糖-聚(乳酸-共-乙醇酸)微球的制备、表征及体外释放研究。
Arch Pharm Res. 2016 Sep;39(9):1242-56. doi: 10.1007/s12272-016-0710-3. Epub 2016 Jan 27.

引用本文的文献

1
Optimizing Process Parameters for Controlled Drug Delivery: A Quality by Design (QbD) Approach in Naltrexone Microspheres.优化控释药物传递的工艺参数:纳曲酮微球中的质量源于设计(QbD)方法。
AAPS PharmSciTech. 2024 May 9;25(5):105. doi: 10.1208/s12249-024-02830-w.
2
The Effect of Different Factors on Poly(lactic-co-glycolic acid) Nanoparticle Properties and Drug Release Behaviors When Co-Loaded with Hydrophilic and Hydrophobic Drugs.不同因素对聚乳酸-乙醇酸共聚物纳米粒性质及同时负载亲水性和疏水性药物时药物释放行为的影响
Polymers (Basel). 2024 Mar 22;16(7):865. doi: 10.3390/polym16070865.
3
Chitosan-coated halloysite nanotube magnetic microspheres for carcinogenic colorectal hemorrhage and liver laceration in albino rats.

本文引用的文献

1
Current trends in PLGA based long-acting injectable products: The industry perspective.基于 PLGA 的长效注射产品的当前趋势:行业视角。
Expert Opin Drug Deliv. 2022 May;19(5):559-576. doi: 10.1080/17425247.2022.2075845. Epub 2022 May 22.
2
PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters.通过乳化和纳米沉淀技术制备聚乳酸-羟基乙酸共聚物纳米颗粒制剂:配方参数的影响
RSC Adv. 2020 Jan 27;10(8):4218-4231. doi: 10.1039/c9ra10857b. eCollection 2020 Jan 24.
3
Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications.
壳聚糖包覆埃洛石纳米管磁性微球用于白化大鼠的致癌性大肠出血和肝裂伤
RSC Adv. 2023 Jul 18;13(31):21521-21536. doi: 10.1039/d3ra01581e. eCollection 2023 Jul 12.
4
Fabrication of biodegradable hollow microsphere composites made of polybutylene adipate co-terephthalate/polyvinylpyrrolidone for drug delivery and sustained release.用于药物递送和缓释的聚己二酸/对苯二甲酸丁二醇酯/聚乙烯吡咯烷酮生物可降解中空微球复合材料的制备
Mater Today Bio. 2023 Apr 6;20:100628. doi: 10.1016/j.mtbio.2023.100628. eCollection 2023 Jun.
5
Synthesis of Controlled-Release Calcium Peroxide Nanoparticles Coated with Dextran for Removal of Doxycycline from Aqueous System.用于从水体系中去除多西环素的葡聚糖包覆控释过氧化钙纳米颗粒的合成
Polymers (Basel). 2022 Sep 15;14(18):3866. doi: 10.3390/polym14183866.
药物纳米晶体:从治疗应用到诊断应用,聚焦脑递送
Pharmaceutics. 2022 Mar 23;14(4):691. doi: 10.3390/pharmaceutics14040691.
4
PLGA-Based Composites for Various Biomedical Applications.用于各种生物医学应用的基于聚乳酸-羟基乙酸共聚物的复合材料
Int J Mol Sci. 2022 Feb 12;23(4):2034. doi: 10.3390/ijms23042034.
5
Nanocrystals based pulmonary inhalation delivery system: advance and challenge.基于纳米晶体的肺部吸入给药系统:进展与挑战。
Drug Deliv. 2022 Dec;29(1):637-651. doi: 10.1080/10717544.2022.2039809.
6
Application of PLGA nanoparticles to enhance the action of duloxetine on microglia in neuropathic pain.PLGA 纳米粒增强度洛西汀对神经病理性疼痛中小胶质细胞作用的应用。
Biomater Sci. 2021 Sep 14;9(18):6295-6307. doi: 10.1039/d1bm00486g.
7
PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up.基于 PLGA 的纳米药物制造:技术概述及工业放大面临的挑战。
Int J Pharm. 2021 Aug 10;605:120807. doi: 10.1016/j.ijpharm.2021.120807. Epub 2021 Jun 16.
8
Merits of sponge-like PLGA microspheres as long-acting injectables of hydrophobic drug.作为疏水性药物的长效注射剂,海绵状 PLGA 微球的优点。
J Biomater Sci Polym Ed. 2019 Dec;30(18):1725-1743. doi: 10.1080/09205063.2019.1659712. Epub 2019 Sep 10.
9
Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.负载白藜芦醇的聚乳酸-羟基乙酸共聚物纳米粒:增强白藜芦醇的稳定性、溶解性及生物活性用于非酒精性脂肪性肝病治疗
R Soc Open Sci. 2018 Nov 14;5(11):181457. doi: 10.1098/rsos.181457. eCollection 2018 Nov.
10
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.PLGA 微/纳米颗粒在生物大分子治疗药物传递中的最新进展。
Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:1041-1060. doi: 10.1016/j.msec.2017.12.036. Epub 2018 Jan 5.